| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.4 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.29 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |